Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Aug 16, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	701	$647.73	59,322
Aug 16, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	766	$648.78	58,556
Aug 16, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	86	$649.54	58,470
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	59	$655.40	61,954
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	58	$656.52	61,896
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	60	$657.51	61,836
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	123	$658.56	61,713
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	77	$660.32	61,636
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	465	$661.46	61,171
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Form 4	Open market or private sale of non-derivative or derivative security	779	$662.57	60,392

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media